Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation | MicrobiomeTrials
Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-08-03Est. Completion: 2027-08
Enrollment target: 30 participants
Locations
Children's Hospital Colorado - Research Institute, Aurora, Colorado, United States
Hassenfeld Children's Hospital at NYU Langone, New York, New York, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Pediatric GI of El Paso, El Paso, Texas, United States
Seattle Children's Hospital - Research Institute, Seattle, Washington, United States